Network medicine in drug design: Implications for neuroinflammation

Drug Discovery Today

Volumn 17, Issue 11-12, 2012, Pages 600-607

  Ghosh, Sourish ^a   Basu, Anirban ^a  

^a National Brain Research Center   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CD1 ANTIGEN; CHEMOKINE; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; VASCULAR CELL ADHESION MOLECULE 1;

ALGORITHM; ANTIGEN EXPRESSION; CELL ACTIVATION; DEGENERATIVE DISEASE; DRUG DESIGN; DRUG TARGETING; GENETIC ASSOCIATION; GLIA CELL; JAPANESE ENCEPHALITIS VIRUS; LINKAGE ANALYSIS; MATHEMATICAL MODEL; MEDIATOR RELEASE; MEDICINE; MICROGLIA; MUTATION; NERVOUS SYSTEM INFLAMMATION; NETWORK MEDICINE; PATHOPHYSIOLOGY; PHOSPHORYLATION; PROBABILITY; REVIEW;

ANIMALS; DRUG DESIGN; HUMANS; MODELS, BIOLOGICAL; MOLECULAR MEDICINE; MOLECULAR TARGETED THERAPY; NEURODEGENERATIVE DISEASES; NEUROGENIC INFLAMMATION;

EID: 84861647487     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.01.018     Document Type: Review

References (59)

1. S. Issazadeh Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells J. Neurosci. Res. 40 1995 579 590
2. W.J. Streit Microglia and neuroinflammation: a pathological perspective J. Neuroinflammation 1 2004 14
3. G. Stoll, and S. Jander The role of microglia and macrophages in the pathophysiology of the CNS Prog. Neurobiol. 58 1999 233 247
4. W.J. Streit Reactive microgliosis Prog. Neurobiol. 57 1999 563 581
5. R.S. Ghirnikar Inflammation in traumatic brain injury: role of cytokines and chemokines Neurochem. Res. 23 1998 329 340
6. S. Jander Interleukin-18 expression after focal ischemia of the rat brain: association with the late-stage inflammatory response J. Cereb. Blood Flow Metab. 22 2002 62 70
7. G. Stoll Lesion-associated expression of transforming growth factor-beta-2 in the rat nervous system: evidence for down-regulating the phagocytic activity of microglia and macrophages Brain Pathol. 14 2004 51 58
8. K. Hensley On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis Antioxid. Redox Signal. 8 2006 2075 2087
9. D.M. Bonifati, and U. Kishore Role of complement in neurodegeneration and neuroinflammation Mol. Immunol. 44 2007 999 1010
10. T.G. Bush Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice Neuron 23 1999 297 308
11. L. Minghetti Role of inflammation in neurodegenerative diseases Curr. Opin. Neurol. 18 2005 315 321
12. P. Eikelenboom The significance of neuroinflammation in understanding Alzheimer's disease J. Neural Transm. 113 2006 1685 1695
13. A. Klegeris Increase in core body temperature of Alzheimer's disease patients as a possible indicator of chronic neuroinflammation: a meta-analysis Gerontology 53 2007 7 11
14. M.G. Tansey Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention Exp. Neurol. 208 2007 1 25
15. T.C. Frank-Cannon Does neuroinflammation fan the flame in neurodegenerative diseases? Mol. Neurodegener. 4 2009 47
16. L.E. Nee A family with histologically confirmed Alzheimer's disease Arch. Neurol. 40 1983 203 208
17. A. Goate Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 349 1991 704 706
18. M. Citron Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production Nature 360 1992 672 674
19. X.D. Cai Release of excess amyloid beta protein from a mutant amyloid beta protein precursor Science 259 1993 514 516
20. F. Lopera Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation JAMA 277 1997 793 799
21. C.A. Lemere The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology Nat. Med. 2 1996 1146 1150
22. B.M. Whalen Small non-fibrillar assemblies of amyloid beta-protein bearing the Arctic mutation induce rapid neuritic degeneration Neurobiol. Dis. 20 2005 254 266
23. P.L. McGeer Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR Neurosci. Lett. 79 1987 195 200
24. W.C. Benzing Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice Neurobiol. Aging 20 1999 581 589
25. J. Koenigsknecht-Talboo, and G.E. Landreth Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines J. Neurosci. 25 2005 8240 8249
26. A. Ghoshal Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis Glia 55 2007 483 496
27. T.D. Gilmore Introduction to NF-κB: players, pathways, perspectives Oncogene 25 2006 6680 6684
28. J. Saklatvala The p38 MAP kinase pathway as a therapeutic target in inflammatory disease Curr. Opin. Pharmacol. 4 2004 372 377
29. A. Nazmi RIG-I mediates innate immune response in mouse neurons following Japanese encephalitis virus infection PLoS One 6 2011 E21761
30. V. Swarup Tumor necrosis factor receptor-1-induced neuronal death by TRADD contributes to the pathogenesis of Japanese encephalitis J. Neurochem. 103 2007 771 783
31. V. Swarup Tumor necrosis factor receptor-associated death domain mediated neuronal death contributes to the glial activation and subsequent neuroinflammation in Japanese encephalitis Neurochem. Int. 52 2008 1310 1321
32. A.L. Barabasi Network medicine: a network-based approach to human disease Nat. Rev. Genet. 12 2011 56 68
33. K.I. Goh The human disease network Proc. Natl. Acad. Sci. U.S.A. 104 2007 8685 8690
34. J.A. DiMasi, and H.G. Grabowski Economics of new oncology drug development J. Clin. Oncol. 25 2007 209 216
35. S. Keyhani Are development times for pharmaceuticals increasing or decreasing? Health Aff. (Millwood) 25 2006 461 468
36. A.J. Wood A proposal for radical changes in the drug-approval process N. Engl. J. Med. 355 2006 618 623
37. M.A. Yildirim Drug-target network Nat. Biotechnol. 25 2007 1119 1126
38. T. Pawson, and R. Linding Synthetic modular systems - reverse engineering of signal transduction FEBS Lett. 579 2005 1808 1814
39. J.M. Irish Mapping normal and cancer cell signalling networks: towards single-cell proteomics Nat. Rev. Cancer 6 2006 146 155
40. J.M. Irish Single cell profiling of potentiated phospho-protein networks in cancer cells Cell 118 2004 217 228
41. K.A. Janes A high-throughput quantitative multiplex kinase assay for monitoring information flow in signaling networks: application to sepsis-apoptosis Mol. Cell Proteomics 2 2003 463 473
42. M.D. Shults A multiplexed homogeneous fluorescence-based assay for protein kinase activity in cell lysates Nat. Methods 2 2005 277 283
43. A.C. Gavin Proteome survey reveals modularity of the yeast cell machinery Nature 440 2006 631 636
44. N.J. Krogan Global landscape of protein complexes in the yeast Saccharomyces cerevisiae Nature 440 2006 637 643
45. J.V. Olsen Global, in vivo, and site-specific phosphorylation dynamics in signaling networks Cell 127 2006 635 648
46. B. Blagoev Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics Nat. Biotechnol. 22 2004 1139 1145
47. J. Cox, and M. Mann Is proteomics the new genomics? Cell 130 2007 395 398
48. P.H. Huang Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma Proc. Natl. Acad. Sci. U.S.A. 104 2007 12867 12872
49. A. Wolf-Yadlin Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks Proc. Natl. Acad. Sci. U.S.A. 104 2007 5860 5865
50. K. Miller-Jensen Common effector processing mediates cell-specific responses to stimuli Nature 448 2007 604 608
51. K.M. Naegle MCAM: multiple clustering analysis methodology for deriving hypotheses and insights from high-throughput proteomic datasets PLoS Comput. Biol. 7 2011 E1002119
52. K. Lage A human phenome-interactome network of protein complexes implicated in genetic disorders Nat. Biotechnol. 25 2007 309 316
53. A.M. Glazier Finding genes that underlie complex traits Science 298 2002 2345 2349
54. D. Botstein, and N. Risch Discovering genotypes underlying human phenotypes: past successes for Mendelian disease, future approaches for complex disease Nat. Genet. 33 Suppl. 2003 228 237
55. S. Kohler Walking the interactome for prioritization of candidate disease genes Am. J. Hum. Genet. 82 2008 949 958
56. S. Navlakha, and C. Kingsford The power of protein interaction networks for associating genes with diseases Bioinformatics 26 2010 1057 1063
57. X. Wu Network-based global inference of human disease genes Mol. Syst. Biol. 4 2008 189
58. O. Vanunu Associating genes and protein complexes with disease via network propagation PLoS Comput. Biol. Comput. Biol. 6 2010
59. A. Kyani Quantitative structure-activity relationships and docking studies of calcitonin gene-related peptide antagonists Chem. Biol. Drug Des. 79 2011 166 176